Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan

S. Hashimoto, Satoshi Tsukada, M. Matsushita, +14

Blood

Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia

M Kawamura, Akira Kikuchi, Shigetoshi Kobayashi, +7

Blood

Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse.

Shigetoshi Kobayashi, Kunihiro Yoshida, Jerrold M. Ward, +8

PubMed

Mhc ClassImmunologyImmune RegulationCell DeathPathology +21

<i>EWS‐FLI‐1</i> and <i>EWS‐ERG</i> chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor

Kohmei Ida, Shigetoshi Kobayashi, Tomohiko Taki, +6

International Journal of Cancer

β2-Microglobulin-Deficient Background Ameliorates Lethal Phenotype of the TGF-β1 Null Mouse

Shigetoshi Kobayashi, Kunihiro Yoshida, Jerrold M. Ward, +8

The Journal of Immunology

Abstract Tgf-β1 NullMhc ClassHuman GrowthImmunodeficienciesImmunology +27

Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.

Akira Kikuchi, Y Hayashi, Shigetoshi Kobayashi, +6

PubMed

Expression pattern of macrophage migration inhibitory factor during embryogenesis

Shigetoshi Kobayashi, Kazuhito Satomura, Jeffrey M. Levsky, +6

Mechanisms of Development

Cell LineageDevelopmental BiologyMedicineMorphogenesisCell Migration +4

Mutations of the Btk gene in 12 unrelated families with X-linked agammaglobulinemia in Japan

Shigetoshi Kobayashi, Tsutomu Iwata, Makiko Saito, +5

Human Genetics

X-linked AgammaglobulinemiaGenetic DisorderGeneticsPathogenesisHematology +6

Induction of bone formation in an adenoid cystic carcinoma of the maxillary sinus by adoptive immunotherapy involving intra-arterial injection of lymphokine-activated killer cells and recombinant interleukin-2 in combination with radiotherapy.

Maria Notomi Sato, Hisahiro Yoshida, Ryuji Kaji, +7

PubMed

Regenerative MedicineLamellar Bone TissueCell TherapyBone Morphogenic ProteinMalignant Disease +11

Guillain–Barré syndrome after BNT162b2 (Pfizer-BioNTec) vaccination

Ken Takahashi, Yoshitaka Tomoda, S Kadena, +3

QJM

VaccinationVaccinologyVaccine DevelopmentImmunologyHumoral Immunity +3